Blair William & Co. IL Sells 2,960 Shares of Cigna Co. (NYSE:CI)

Blair William & Co. IL decreased its holdings in shares of Cigna Co. (NYSE:CIGet Rating) by 5.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,550 shares of the health services provider’s stock after selling 2,960 shares during the period. Blair William & Co. IL’s holdings in Cigna were worth $11,633,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Country Trust Bank raised its stake in shares of Cigna by 116.7% in the first quarter. Country Trust Bank now owns 104 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 56 shares during the last quarter. Wagner Wealth Management LLC increased its holdings in shares of Cigna by 144.4% in the fourth quarter. Wagner Wealth Management LLC now owns 132 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 78 shares in the last quarter. Exane Derivatives increased its holdings in shares of Cigna by 6,200.0% in the first quarter. Exane Derivatives now owns 126 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 124 shares in the last quarter. Lloyd Advisory Services LLC. acquired a new stake in shares of Cigna in the first quarter valued at approximately $30,000. Finally, Vectors Research Management LLC acquired a new stake in shares of Cigna in the fourth quarter valued at approximately $31,000. Institutional investors own 89.54% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Oppenheimer raised their price target on shares of Cigna from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, August 8th. Barclays raised their price target on shares of Cigna from $275.00 to $310.00 and gave the company an “overweight” rating in a report on Monday, May 23rd. Mizuho lifted their target price on shares of Cigna from $291.00 to $330.00 and gave the stock a “buy” rating in a report on Friday, August 5th. JPMorgan Chase & Co. raised shares of Cigna from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $248.00 to $304.00 in a report on Monday, May 16th. Finally, SVB Leerink lifted their target price on shares of Cigna from $276.00 to $305.00 and gave the stock a “market perform” rating in a report on Wednesday, August 10th. Seven analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Cigna has an average rating of “Moderate Buy” and an average target price of $305.58.

Insiders Place Their Bets

In other Cigna news, CEO Eric P. Palmer sold 6,521 shares of the business’s stock in a transaction dated Thursday, July 7th. The shares were sold at an average price of $275.00, for a total transaction of $1,793,275.00. Following the sale, the chief executive officer now directly owns 39,978 shares of the company’s stock, valued at approximately $10,993,950. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, insider Jason D. Sadler sold 3,458 shares of the business’s stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $270.00, for a total transaction of $933,660.00. Following the transaction, the insider now directly owns 31,749 shares in the company, valued at approximately $8,572,230. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Palmer sold 6,521 shares of the business’s stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $275.00, for a total transaction of $1,793,275.00. Following the transaction, the chief executive officer now owns 39,978 shares in the company, valued at $10,993,950. The disclosure for this sale can be found here. Insiders have sold 32,898 shares of company stock valued at $9,163,758 in the last three months. 0.80% of the stock is currently owned by corporate insiders.

Cigna Trading Up 0.2 %

CI opened at $290.71 on Friday. The stock has a market capitalization of $88.70 billion, a P/E ratio of 17.34, a P/E/G ratio of 1.11 and a beta of 0.71. Cigna Co. has a 12 month low of $191.74 and a 12 month high of $293.96. The firm’s fifty day simple moving average is $280.19 and its 200 day simple moving average is $261.29. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67.

Cigna (NYSE:CIGet Rating) last posted its quarterly earnings data on Thursday, August 4th. The health services provider reported $6.22 EPS for the quarter, beating the consensus estimate of $5.62 by $0.60. The business had revenue of $45.48 billion for the quarter, compared to analysts’ expectations of $44.34 billion. Cigna had a net margin of 3.05% and a return on equity of 15.91%. The firm’s revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.24 EPS. As a group, research analysts anticipate that Cigna Co. will post 22.97 EPS for the current fiscal year.

Cigna Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 22nd. Shareholders of record on Wednesday, September 7th will be given a dividend of $1.12 per share. The ex-dividend date is Tuesday, September 6th. This represents a $4.48 annualized dividend and a yield of 1.54%. Cigna’s dividend payout ratio (DPR) is presently 26.71%.

Cigna Profile

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Co. (NYSE:CIGet Rating).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.